Peptide Drugs List: FDA-Approved and Top-Selling Peptides

This peptide drugs list covers FDA-approved options, top-selling peptide drugs, and how many peptide drugs approved by FDA—plus key safety notes.

ARTICLE OVERVIEW

This peptide drugs list covers FDA-approved options, top-selling peptide drugs, and how many peptide drugs approved by FDA—plus key safety notes.

A peptide drugs list is an inventory of medications whose active ingredient is a short chain of amino acids rather than a small molecule. The U.S. Food and Drug Administration has approved roughly 80 to 100 peptide-based drug products for human use, depending on how generics, formulations, and discontinued products are counted. Most of those approvals cover injectable hormones, diabetes drugs, cancer therapies, and rare-disease treatments — not general wellness products.

Peptide drugs are not a single therapeutic class. They include insulin, GLP-1 receptor agonists, fertility hormones, peptide antibiotics, and antivirals, and each one carries its own dosing rules, side effects, and prescribing requirements.

How Many Peptide Drugs Are Approved by the FDA?

Exact counts vary because the FDA approves active ingredients, brand products, generics, and new formulations separately. Counting unique active peptide ingredients, the agency has cleared roughly 80 to 100 for human use in the United States. Counting every branded and generic product, the total runs into the hundreds.

The FDA does not publish a single master peptide drugs list. Researchers build these lists by filtering approval databases for peptide sequences and then removing large proteins such as monoclonal antibodies.

Approvals cluster in a handful of therapeutic areas:

  • Metabolic and diabetes care: insulin analogs, GLP-1 agonists, amylin analogs
  • Endocrinology: GnRH agonists and antagonists, somatostatin analogs, vasopressin analogs
  • Oncology: peptide-based radiopharmaceuticals and supportive-care agents
  • Infectious disease: peptide antibiotics such as bacitracin, colistin, and daptomycin
  • Rare disease and diagnostics: selected hormones and imaging peptides

Peptide drugs are rarely first-line treatments for common conditions, and most require a prescription plus ongoing clinical monitoring.

FDA-Approved Peptide Drugs List: Selected Examples

The table below is not exhaustive, but it covers the peptide drug categories most patients and clinicians encounter in practice.

Generic nameCommon brandPrimary use
Insulin glargineLantus, ToujeoLong-acting insulin for diabetes
SemaglutideOzempic, Wegovy, RybelsusType 2 diabetes and chronic weight management
TirzepatideMounjaro, ZepboundType 2 diabetes and chronic weight management
LiraglutideVictoza, SaxendaDiabetes and weight management
DulaglutideTrulicityType 2 diabetes
LeuprolideLupron, EligardProstate cancer, endometriosis, fertility
OctreotideSandostatinAcromegaly and neuroendocrine tumors
DesmopressinDDAVPDiabetes insipidus and bleeding disorders
DaptomycinCubicinSerious gram-positive infections
ColistimethateColy-Mycin MMultidrug-resistant infections
Glatiramer acetateCopaxoneRelapsing multiple sclerosis
TeriparatideForteoOsteoporosis

Formulation matters as much as the molecule. The same peptide can appear as a daily injection, a once-weekly injection, an oral tablet, or a long-acting implant, and each version carries its own approval and label.

Top-Selling Peptide Drugs

Revenue makes the ranking straightforward. Insulin and GLP-1 receptor agonists are the top-selling peptide drugs worldwide by a wide margin, and a small number of brands generate most of that revenue.

Sales tierProductCompanyMain driver
1Semaglutide (Ozempic, Wegovy)Novo NordiskDiabetes and obesity
2Tirzepatide (Mounjaro, Zepbound)Eli LillyDiabetes and obesity
3Insulin glargine (Lantus, Toujeo)SanofiLong-acting insulin
4Dulaglutide (Trulicity)Eli LillyType 2 diabetes
5Liraglutide (Victoza, Saxenda)Novo NordiskDiabetes and obesity

Why GLP-1 Peptides Dominate the Market

Semaglutide and tirzepatide paired diabetes indications with weight-loss approvals and strong trial results, which pushed demand far beyond earlier peptide drugs. Their sales growth outpaced older insulin products within a few years of launch.

High demand also triggered shortages and a wave of counterfeit and compounded versions, which regulators have repeatedly warned about.

What Is Not on the FDA-Approved Peptide Drugs List

Many compounds marketed online as peptides have never been approved for human use. BPC-157, TB-500, CJC-1295, ipamorelin, and retatrutide all fall into that category.

BPC-157 and TB-500 are sold as research chemicals and are not FDA-approved for human use in the United States. Retatrutide remains investigational, which means it can only be obtained legally through an authorized clinical trial.

Search interest in peptide warehouse retatrutide shows how quickly gray-market demand follows trial news, even when no approved product exists. Forums also fill with peptide warehouse reddit review threads that mix anecdotes with marketing, which makes them unreliable sources of safety information.

Shoppers who search for peptide warehouse usa are usually trying to find a domestic seller, while peptide warehouse uk results reflect the United Kingdom's separate regulatory framework. Neither search guarantees a legal, tested, or pharmaceutical-grade product.

Legitimate sourcing questions usually start with peptide manufacturers usa that hold FDA registration and publish certificates of analysis. That is a very different standard from a website shipping unlabeled vials with no batch documentation.

Approved peptide drugs carry real risks. Insulin can cause dangerous hypoglycemia, GLP-1 agonists commonly cause nausea and gastrointestinal side effects, and many peptide hormones require regular blood work.

Unapproved peptides carry unknown risks. They may be mislabeled, dosed incorrectly, contaminated, or produced without sterility controls.

No peptide sold as a research chemical has been evaluated by the FDA for safety, effectiveness, or manufacturing quality in humans.

Anyone considering a peptide for a health condition should talk with a licensed healthcare professional instead of self-prescribing from an online list.

How to Read a Peptide Drugs List Critically

  • Confirm approval status in the FDA's official drug databases, not on a vendor page.
  • Separate active ingredients from brand names and generics.
  • Distinguish prescription drugs from dietary supplements and cosmetics.
  • Treat sales rankings as revenue signals, not as evidence of safety or suitability.
  • Skip any list that never cites a regulatory source.

A credible peptide drugs list names the active ingredient, the approval status, the approved indication, and the delivery method. Anything less is marketing copy rather than medical information.

Frequently Asked Questions

How many peptide drugs are approved by the FDA?

The FDA has approved roughly 80 to 100 unique peptide active ingredients for human use in the United States. The exact number depends on whether generics, discontinued products, and multiple formulations of the same molecule are counted. Counting every branded and generic product pushes the total into the hundreds.

What are the top-selling peptide drugs?

Insulin products and GLP-1 receptor agonists dominate peptide drug sales worldwide. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are the fastest-growing, followed by insulin glargine, dulaglutide, and liraglutide.

Are research peptides like BPC-157 legal to buy in the US?

BPC-157, TB-500, and similar compounds are not FDA-approved for human use. They are widely sold as research chemicals, which is a legal gray area, and they are not evaluated for safety, purity, or sterility. Buying them for personal use is not a substitute for a prescribed, approved medication.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.